Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Alrex (Loteprednol Etabonate) Ophthalmic Suspension, 0.2% Bausch and Lomb NDA 20803 Lotemax (Loteprednol Etabonate), 0.5% Bausch and Lomb NDA 20-841 3/9/98 3/9/98 6/25/98 4/11/02 Lotemax (Loteprednol Etabonate), Ophthalmic Suspension, 0.5% Pharmos NDA 20-583 | Zylet (loteprednol etabonate and tobramycin) ophthalmic suspension, Bausch & Lomb, Approval | Zylet (loteprednol etabonate and tobramycin) Ophthalmic Suspension, Bausch & Lomb, Inc., Labeling Revision | Lotemax (loteprednol etabonate) Ophthalmic Ointment, Bausch & Lomb Inc. Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com